ArKal Medical Raises $17.5M
Fremont-based ArKal Medical said today that the firm has raised $17.5M in a Series B financing round. The firm, which is developing a continuous glucose monitoring system for managing diabetes, said the round was led by Thomas Mcnerney & Partners. Delphi Ventures and MedVenture Associates also participated in the round. ArKal's products are intended to replace current glucose monitoring systems.
posted on Tuesday, September 16, 2008 (Link to more information)
Related companies:
Arkal Medical
Related stories:
> Vertos Medical Raises $12M
> Halt Medical Raises $15M
> Providence Medical Technology Raises $10.5M
> Sadra Medical Raises $19M
> ADVANCE Medical Raises $6M
silicontap.com Home